Viral infections in bivalves represent a significant and often devastating category of diseases affecting oysters, clams, mussels, scallops, and related mollusks worldwide. Unlike bacterial or parasitic infections that may be amenable to treatment, viral diseases in invertebrates generally cannot be cured and must be managed through supportive care, environmental optimization, and prevention strategies. The most well-documented bivalve viruses include Ostreid herpesvirus (OsHV-1) affecting oysters, various iridoviruses, and a range of poorly characterized viral agents that cause disease in multiple bivalve families. These pathogens have caused mass mortality events in aquaculture operations and wild populations, demonstrating their capacity for rapid spread and significant ecological and economic impact.
Viral infections can affect virtually all bivalve species, though oysters have been most extensively studied due to their commercial importance and the dramatic die-offs caused by OsHV-1 variants. Pacific oysters demonstrate particular susceptibility to herpesvirus infections, with mortality rates sometimes exceeding ninety percent in affected populations. Other commercially important species including Eastern oysters, European flat oysters, and various clam species are susceptible to their own viral pathogens or variants of cross-species viruses. Freshwater mussels and clams remain poorly studied regarding viral diseases, though emerging evidence suggests they also harbor viral agents capable of causing disease under stress conditions.
The impact of viral infections on bivalve health extends beyond direct mortality to include growth suppression, reproductive failure, and increased susceptibility to secondary infections. Subclinical viral infections may persist in apparently healthy populations, flaring into acute disease when environmental stressors compromise host immunity. The filter-feeding nature of bivalves makes them particularly vulnerable to viral acquisition, as they constantly process large volumes of water that may contain viral particles shed by infected individuals. Larvae and juvenile bivalves typically suffer higher mortality rates than adults, though no life stage is immune to viral disease.
The treatability of viral infections in bivalves remains severely limited by the fundamental challenges of antiviral therapy in invertebrates. No approved antiviral medications exist for bivalve use, and the pharmacology of potential treatments remains largely unexplored. Management focuses on optimizing environmental conditions to support immune function, preventing spread through biosecurity measures, and selectively breeding for disease resistance in aquaculture settings. For individual keepers, this translates to isolation of affected animals, maintenance of optimal water quality, and acceptance that mortality may occur despite best efforts. Prevention through quarantine, stress reduction, and avoidance of introducing potentially infected stock remains the most effective approach to viral disease management.
